Cover Image
Market Research Report

Europe Antihypertensive Drugs Market Forecast 2019-2028

Published by Inkwood Research Product code 943440
Published Content info 121 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Antihypertensive Drugs Market Forecast 2019-2028
Published: June 21, 2020 Content info: 121 Pages
Description

KEY FINDINGS

The Europe antihypertensive drugs market is estimated to grow with an anticipated CAGR of 2.70% during the forecast years of 2019 to 2028. The region also accounted for harboring the second-largest market share in terms of revenue, in 2019.

MARKET INSIGHTS

Countries included for analyzing the Europe antihypertensive drugs market growth are France, Germany, Russia, Belgium, the United Kingdom, Italy, Poland, and the rest of Europe. The presence of key players like Novartis AG, Sanofi, and AstraZeneca Plc, ensure easy availability of antihypertensive drugs in the region. Moreover, an increased prevalence of a vast patient base suffering from hypertension drives market growth. In Germany, increasing healthcare expenses and a rise in aging residents have been beneficial for the antihypertensive drugs market growth. The incidence of chronic disorders like blood pressure, asthma, and diabetes, among others, has resulted in the majority of deaths in the country. This is likely to promote Germany's antihypertensive drugs market growth. According to the latest projections by the United Nations, Italy's population in 2019 was estimated at 60.55 million. In the same year, 29.4% of the country's population was over 60 years old. This figure is expected to rise to a massively by 2050. In Italy, over 24 million people suffered from chronic disorders in 2018. Therefore, the increase in the geriatric population, along with a rise in chronic diseases, is predicted to fuel the market growth. Poland's market growth is expected to be propelled by the mortality rate due to chronic obstructive pulmonary disease (COPD) as well as the upsurge in aging individuals.

COMPETITIVE INSIGHTS

Some of the notable companies in the market are Medtronic Plc, Daiichi Sankyo Company Limited, Novartis AG, Boehringer Ingelheim International GmbH, Pfizer Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32276

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

1. STUDY OBJECTIVES

2. SCOPE OF STUDY

3. METHODOLOGY

4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

1. MARKET SIZE & ESTIMATES

2. MARKET OVERVIEW

3. MARKET DYNAMICS

1. MARKET DEFINITION

2. KEY DRIVERS

    • 3.2.1. GROWING PREVALENCE OF HYPERTENSION ACROSS THE GLOBE
    • 3.2.2. SURGE IN DISPOSABLE INCOME AND HEALTHCARE SPENDING
    • 3.2.3. RISING AGING POPULATION

3. KEY RESTRAINTS

    • 3.3.1. PATENT EXPIRATIONS
    • 3.3.2. DELAY IN PRODUCT LAUNCHES

4. KEY ANALYTICS

1. PORTER'S FIVE FORCE ANALYSIS

    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY

2. REGULATORY FRAMEWORK

3. OPPORTUNITY MATRIX

4. VENDOR LANDSCAPE

5. KEY INVESTMENT INSIGHTS

5. MARKET BY DRUG CLASS

1. CALCIUM CHANNEL BLOCKERS

2. ACE INHIBITORS

3. BETA-ADRENERGIC BLOCKERS

4. DIURETICS

5. VASODILATORS

6. OTHER DRUG CLASS

6. MARKET BY END-USER

1. HOSPITAL PHARMACY

2. RETAIL PHARMACY

3. E-COMMERCE WEBSITES & ONLINE DRUG STORES

7. GEOGRAPHICAL ANALYSIS

1. EUROPE

    • 7.1.1. THE UNITED KINGDOM
    • 7.1.2. FRANCE
    • 7.1.3. GERMANY
    • 7.1.4. ITALY
    • 7.1.5. RUSSIA
    • 7.1.6. BELGIUM
    • 7.1.7. POLAND
    • 7.1.8. REST OF EUROPE

8. COMPANY PROFILES

1. ALLERGAN PLC

2. ASPIRE BARIATRICS INC

3. ASTRAZENECA PLC

4. BIO-RAD LABORATORIES INC

5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH

6. DAIICHI SANKYO COMPANY LIMITED

7. HILL-ROM HOLDINGS INC

8. JOHNSON & JOHNSON

9. LUPIN LIMITED

  • 8.10. MEDTRONIC PLC
  • 8.11. MERCK & CO INC
  • 8.12. NOVARTIS AG
  • 8.13. PFIZER INC
  • 8.14. SANOFI
  • 8.15. SUN PHARMACEUTICAL INDUSTRIES LTD (RANBAXY LABORATORIES)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - ANTIHYPERTENSIVE DRUGS
  • TABLE 2: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
  • TABLE 3: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028, (IN $ MILLION)
  • TABLE 4: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
  • TABLE 5: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028, (IN $ MILLION)
  • TABLE 6: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORIC YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, IN 2019
  • FIGURE 6: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY CALCIUM CHANNEL BLOCKERS, 2019-2028 (IN $ MILLION)
  • FIGURE 7: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY ACE INHIBITORS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY BETA-ADRENERGIC BLOCKERS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DIURETICS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY VASODILATORS, 2019-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY OTHER DRUG CLASS, 2019-2028 (IN $ MILLION)
  • FIGURE 12: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, IN 2019
  • FIGURE 13: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY HOSPITAL PHARMACY, 2019-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY RETAIL PHARMACY, 2019-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY E-COMMERCE WEBSITES & ONLINE DRUG STORES, 2019-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 17: THE UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 18: FRANCE ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GERMANY ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 20: ITALY ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 21: RUSSIA ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 22: BELGIUM ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: POLAND ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 24: REST OF EUROPE ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
Back to Top